Biogen
BIIB
#864
Rank
NZ$39.30 B
Marketcap
$269.74
Share price
-0.07%
Change (1 day)
-29.66%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Cash on Hand

Cash on Hand as of September 2024 : NZ$2.90 Billion

According to Biogen's latest financial reports the company has NZ$2.90 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Biogen - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$1.66 B-78.46%
2022-12-31NZ$7.70 B38.43%
2021-12-31NZ$5.56 B53.9%
2020-12-31NZ$3.61 B-45.57%
2019-12-31NZ$6.64 B26%
2018-12-31NZ$5.27 B1.54%
2017-12-31NZ$5.19 B-26.5%
2016-12-31NZ$7.06 B41.07%
2015-12-31NZ$5.00 B112.69%
2014-12-31NZ$2.35 B58.29%
2013-12-31NZ$1.48 B-28.24%
2012-12-31NZ$2.07 B-4.28%
2011-12-31NZ$2.16 B38.38%
2010-12-31NZ$1.56 B-10.02%
2009-12-31NZ$1.73 B-24.76%
2008-12-31NZ$2.31 B49.67%
2007-12-31NZ$1.54 B20.58%
2006-12-31NZ$1.28 B2.94%
2005-12-31NZ$1.24 B324.05%
2004-12-31NZ$0.29 B-39.4%
2003-12-31NZ$0.48 B-67.82%
2002-12-31NZ$1.50 B-21.68%
2001-12-31NZ$1.92 B24.81%
2000-12-31NZ$1.53 B22.95%
1999-12-31NZ$1.25 B27.69%
1998-12-31NZ$0.98 B29.34%
1997-12-31NZ$0.75 B66.72%
1996-12-31NZ$0.45 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$15.39 B 430.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.73 B 63.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.44 B 328.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.00 B 485.69%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$34.67 B 1,094.50%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$15.99 M-99.45%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.44 B 328.68%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$2.77 B-4.52%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.60 B-44.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.52 B-47.61%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands